B Hu1, J Ellingboe, S Han
1Chemical Sciences and Cardiovascular/Metabolic Diseases Research, Wyeth-Ayerst Research, Pearl River, New York 10965, USA. hub@war.wyeth.com
Researchers developed novel (4-piperidin-1-yl)phenyl amides as potential treatments for obesity and type II diabetes. Compounds 26e and 33b demonstrated high potency and selectivity as human beta(3) adrenergic receptor agonists.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: